Bivalirudin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

24 Suppliers, 14 USDMF, 1 EU WC, 11 NDC API, 15 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

31 Dossiers, 17 FDA Orange Book, 5 Europe, 4 Canada, 1 Australia, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - 250MG/50ML (5MG/ML), SOLUTION;INTRAVENOUS - 500MG/100ML (5MG/ML), INJECTABLE;INTRAVENOUS - 250MG/VIAL

RELATED EXCIPIENT COMPANIES

Suppliers, 12 SPI Pharma, 3 Actylis, 3 Roquette, 2 Microlex e.U, 2 Gangwal Healthcare, 2 Gangwal Chemicals, 2 Kerry, 1 Rochem International Inc, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Ingredion Pharma Solutions, 1 Pfanstiehl, 1 DKSH, 1 BASF, 1 Shijiazhuang Huaxu Pharmaceutical

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 6 Parenteral, 4 Co-Processed Excipients, 3 Granulation, 3 Disintegrants & Superdisintegrants, 1 Thickeners and Stabilizers, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

3 Finished Drug Prices

3 Finished Drug Prices

MARKET PLACE

4 APIs, 1 DOSSIERS // FDF

PATENTS

6 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 21 News

Pharmacy pricing data of Bivalirudin obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Bivalirudin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

24 Suppliers

14 USDMF

1 EU WC

11 NDC API

15 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

31 Dossiers

17 FDA Orange Book

5 Europe

4 Canada

1 Australia

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - 250MG/50ML (5MG/ML)

SOLUTION;INTRAVENOUS - 500MG/100ML (5MG/ML)

INJECTABLE;INTRAVENOUS - 250MG/VIAL

RELATED EXCIPIENT COMPANIES

Suppliers

12 SPI Pharma

3 Actylis

3 Roquette

2 Microlex e.U

2 Gangwal Healthcare

2 Gangwal Chemicals

2 Kerry

1 Rochem International Inc

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Sigachi Industries

1 Ingredion Pharma Solutions

1 Pfanstiehl

1 DKSH

1 BASF

1 Shijiazhuang Huaxu Pharmaceutical

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

10 Direct Compression

10 Chewable & Orodispersible Aids

9 Taste Masking

6 Parenteral

4 Co-Processed Excipients

3 Granulation

3 Disintegrants & Superdisintegrants

1 Thickeners and Stabilizers

1 API Stability Enhancers

GLOBAL SALES INFORMATION

3 Finished Drug Prices

MARKET PLACE

4 APIs

1 DOSSIERS // FDF

PATENTS

6 US Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

21 News

Bivalirudin

THE MEDICINES COMPANY UK LTD

Bivalirudin

Angiox

Bivalirudin 250Mg 10 Units Par...

10 VIALS EV 250 mg

3,790.50

6,255.85

Euro

Class H